• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    27.29 Up 0.41(1.53%) May 27, 4:00PM EDT
    |After Hours : 27.30 Up 0.01 (0.02%) May 27, 4:25PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 115,904   130,902   148,199   113,708  
    Cost of Revenue23,345  26,559  24,900  22,867  
    Gross Profit 92,559   104,343   123,299   90,841  
    Operating Expenses
    Research Development44,570  43,988  43,356  31,229  
    Selling General and Administrative65,180  56,485  54,256  53,920  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (17,191) 3,870   25,687   5,692  
    Income from Continuing Operations
    Total Other Income/Expenses Net10,657  159  61  444  
    Earnings Before Interest And Taxes(6,534)4,029  25,748  6,136  
    Interest Expense3,723  3,374  4,037  4,010  
    Income Before Tax(10,257)655  21,711  2,126  
    Income Tax Expense(9,737)(8,550)17,770  1,129  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(520)9,205  3,941  997  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (520) 9,205   3,941   997  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (520) 9,205   3,941   997  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.